herpes zoster neuralgia
Conditions
Interventions
test group:Administration of daily oral famciclovir 250 mg tid and pregabalin 75-150 mg Q12, along with ultrasound-guided platelet-rich plasma injections in the dorsal root ganglion
control group:Administration of daily oral famciclovir 250 mg tid, pregabalin 75-150 mg Q12, and concomitant ultrasound-guided dorsal root ganglion anti-inflammatory and analgesic fluid injections wer
Sponsors
Shengli Oilfield Central Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: ? The duration of acute-phase herpes zoster neuralgia is <1 month. ? The site of onset was unilateral cervical, thoracic and lumbar segments. ? Score 4-6 on the numerical rating scale method, and the patient is able to objectively evaluate his/her own pain and score it. ? No serious systemic diseases such as cardiopulmonary, hepatic, or renal diseases, and received dorsal root ganglion PRP and anti-inflammatory and analgesic liquid injection treatment and follow-up.
Exclusion criteria
Exclusion criteria: ? Significant pain from other causes. ? Suffering from psychosomatic diseases. ? Coagulation disorders, infection at the puncture site or other systemic infections. ? There are other conditions that cannot cooperate with the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate 1 month after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregabalin dosage;Pittsburgh Sleep Quality Index; | — |
Countries
China
Contacts
Public ContactGe Weipeng
Shengli Oilfield Central Hospital
Outcome results
None listed